Market Research Report - 244596
2012 US Strategic Analysis of the Coagulation Testing Market: Forecasts and Supplier Shares
|Published by||Venture Planning Group|
|2012 US Strategic Analysis of the Coagulation Testing Market: Forecasts and Supplier Shares|
This comprehensive report is designed to help current suppliers and potential market entrants identify and evaluate growth opportunities and strategies emerging in the US coagulation testing market during this decade. The report explores business and technological trends; provides estimates of the test volume for 35 assays, as well as sales and market shares of leading reagent and instrument suppliers; compares features of major analyzers; profiles leading market players; and identifies specific product and business opportunities facing instrument and consumable suppliers.
The growing cost-containment pressures in major industrialized nations, coupled with continued technological advances in molecular diagnostics, chromagenic substrates, monoclonal antibodies, immunoassays, IT and laboratory automation will radically change coagulation testing practice.
Specific and sensitive markers of hemostasis will be increasingly used on automated instrumentation. Coagulation testing will also become more standardized, offering opportunities for quality control products and services. Moreover, the continuing contraction of the hospital system and technological advances will facilitate decentralization of the coagulation testing closer to the patient, thus creating POC opportunities and challenges for suppliers.
The report is based on a combination of primary and secondary information sources, including interviews with laboratory directors, and executives of leading diagnostics companies and start-up firms developing innovative products.
In addition to primary sources of information, a comprehensive review of the most recent technical and business publications, manufacturer product and financial literature, and Venture Planning Group's proprietary data files was conducted.
Contains: 380 pages and 7 tables.
The report analyzes capabilities and features of major automated, semi-automated, and POC analyses marketed by Bio/Data, Cardiovascular Diagnostics, Diagnostica Stago/Trinity, Helena, Instrumentation Laboratory, Roche, Siemens, Sysmex and other suppliers.
Technologies reviewed include molecular diagnostics, chromogenic substrates, monoclonal and polyclonal antibodies, immunoassays, microcomputers, automation, robotics, artificial intelligence, dry chemistry, biosensors and others.
USA: Business Environment, Market Forecasts, Supplier Sales and Market Shares